Professor John Pezacki and his team have engineered a groundbreaking enzyme capable of targeting and degrading harmful non-coding RNA (ncRNA), which plays a role in cancer and viral infections. Using genetic code expansion technologies, the team developed the first-ever artificial enzyme that can selectively cut small ncRNA molecules. This innovation promises to advance antiviral therapies and can...
Professor John Pezacki and his team have engineered a groundbreaking enzyme capable of targeting and degrading harmful non-coding RNA (ncRNA), which plays a role in cancer and viral infections. Using genetic code expansion technologies, the team developed the first-ever artificial enzyme that can se...
June 16, 2025